News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial ResistanceNext XORTX Announces Participation at Upcoming Investor Conferences Related Stories News Melodofi President Paul Ogunmefun to Appear as Music & Tech Panelist at The Linq Up BET Awards Weekend in Los Angeles News Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China News PT Merdeka Gold Resources Tbk Debuts on the Main Board of HKEX with a Secondary Listing News Tong Ren Tang Healthcare (02667.HK) Targets Hong Kong IPO News IP Go-Global Business Matching Session held in Guangzhou News Kyivstar and VEON Partner with Ministry of Economy, Environment and Agriculture of Ukraine to Accelerate AI Infrastructure and Digital Economy Growth